Leukemia Clinical Trials in Barcelona, Catalonia
4 recruitingBarcelona, Catalonia, Spain
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Merck Sharp & Dohme LLC1,200 enrolled195 locationsNCT06136559
Recruiting
Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Amgen304 enrolled192 locationsNCT04994717
Recruiting
Phase 2
Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Acute Myeloid Leukemia
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias29 enrolled14 locationsNCT06668558
Recruiting
European Rare Blood Disorders Platform (ENROL)
LeukemiaMyelomaAnemia+9 more
Hospital Universitari Vall d'Hebron Research Institute37,090 enrolled1 locationNCT06250595